Dermatosis Papulosa Nigra Clinical Trial
Official title:
A Phase 2 Open Label Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
Evaluate the safety and efficacy of hydrogen peroxide, A-101 Solution 40% for the treatment of DPN lesions on subjects with a Fitzpatrick Skin Type of 5 or 6.
The main objective of this study is to evaluate the safety and efficacy of hydrogen peroxide,
A-101 Solution 40% for the treatment of DPN lesions on subjects with a Fitzpatrick Skin Type
of 5 or 6.
The secondary objectives of this study include:
- Durability of response
- Safety
An exploratory objective of this study will evaluate the subject's assessment of the
treatment of A-101 to DPN lesions using a Subject Self-Assessment Scale.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06099080 -
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)
|
Phase 2 |